Cargando…

Patient-Reported Outcomes in Ovarian Cancer: Facilitating and Enhancing the Reporting of Symptoms, Adverse Events, and Subjective Benefit of Treatment in Clinical Trials and Clinical Practice

Patient-reported outcomes (PROs) provide a valid, standardized way of assessing symptoms, adverse events and the subjective benefit of treatment from the patient’s perspective. Assessment of PROs is critical in ovarian cancer due to the high morbidity of the disease and its treatments. Several well-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Rachel, King, Madeleine T, Stockler, Martin R, Lee, Yeh Chen, Roncolato, Felicia T, Friedlander, Michael L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178904/ https://www.ncbi.nlm.nih.gov/pubmed/37188148 http://dx.doi.org/10.2147/PROM.S297301

Ejemplares similares

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study
por: Lee, Yeh Chen, et al.
Publicado: (2022)

A systematic evaluation of compliance and reporting of patient-reported outcome endpoints in ovarian cancer randomised controlled trials: implications for generalisability and clinical practice
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2017)

The importance of patient-reported outcomes in clinical trials and strategies for future optimization
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2018)

Effect Sizes Hypothesized and Observed in Contemporary Phase III Trials of Targeted and Immunological Therapies for Advanced Cancer
por: Lawrence, Nicola Jane, et al.
Publicado: (2018)

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma
por: Najjar, Mimi, et al.
Publicado: (2023)

Medical students as junior adverse drug event managers facilitating reporting of ADRs
por: Reumerman, Michael O., et al.
Publicado: (2021)

An external facilitation intervention to increase uptake of an adverse drug event reporting intervention
por: Lau, Erica Y., et al.
Publicado: (2023)

Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System
por: Gong, Li, et al.
Publicado: (2020)

A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
por: Wilson, Michelle K., et al.
Publicado: (2018)

Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity
por: Sartor, Oliver
Publicado: (2017)

Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
por: Le-Rademacher, Jennifer G., et al.
Publicado: (2019)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Adverse clinical events caused by pacemaker battery depletion: two case reports
por: Liu, Junpeng, et al.
Publicado: (2020)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2016)

The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training
por: Mercieca-Bebber, Rebecca, et al.
Publicado: (2017)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

German translation and validation of the Reporting of Clinical Adverse Events Scale (RoCAES-D)
por: Litke, Nicola Alexandra, et al.
Publicado: (2020)

Quality of reporting of adverse events in clinical trials of covid-19 drugs: systematic review
por: Madi, Karima, et al.
Publicado: (2023)

Completeness of adverse drug reactions reports of the Saudi adverse event reporting system
por: Alshammari, Thamir M., et al.
Publicado: (2015)

Adverse Event Profiles of Platinum Agents: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers
por: Wang, Yanni, et al.
Publicado: (2022)

Benefits and adverse events of melatonin use in the elderly (Review)
por: Anghel, Lucreția, et al.
Publicado: (2022)

Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports
por: Kato, Yamato, et al.
Publicado: (2015)

Adverse Event Profiles of 5-Fluorouracil and Capecitabine: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS, and Reproducibility of Clinical Observations
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Adverse event reporting in randomised trials of neuropathic pain: challenges for clinical usefulness of safety data
por: Cornelius, Victoria R, et al.
Publicado: (2011)

Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trial
por: Bolland, Mark J, et al.
Publicado: (2013)

Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?
por: Hana, David, et al.
Publicado: (2022)

Reporting of adverse events associated with spinal manipulation in randomised clinical trials: an updated systematic review
por: Gorrell, Lindsay M, et al.
Publicado: (2023)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report
por: Shen, Chia-I, et al.
Publicado: (2021)

Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning
por: Ménard, Timothé, et al.
Publicado: (2019)

Standardizing adverse drug event reporting data
por: Wang, Liwei, et al.
Publicado: (2014)

Seasonal and Geographic Variation in Adverse Event Reporting
por: Marrero, Osvaldo, et al.
Publicado: (2016)

Chloroquine: Psychiatric adverse events: case report
Publicado: (2020)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han, Nayoung, et al.
Publicado: (2021)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b2tffqkrh9kusjnn2oo59u66sq